Lupin partners with Sandoz to market, commercialize Ranibizumab biosimilar across multiple regions Ruchika Sharma12 Aug 2025 5:21 PM ISTLupin will be responsible for manufacturing the product and for regulatory submissions.
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India Parthika Patel6 Aug 2025 3:34 PM ISTNew Delhi: Roche Products (India) Pvt Ltd has been directed by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
OSA increases the risk of retinal vein occlusion in Hispanic/Latino population: Study Jacinthlyn Sylvia25 July 2025 8:00 AM ISTA new study published in the journal of Eye showed that in some ethnic groups like the non-Hispanic Whites and Hispanic/Latinos, obstructive sleep...
Diabetes Patients with RVO and Prior CME at higher risk of Macular Edema After Cataract Surgery: Study Dr. Shravani Dali23 May 2025 8:45 AM ISTA recent study published in the Indian Journal of Ophthalmology has identified significant risk factors for postoperative macular edema (PME)...
BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's Ranibizumab Biosimilar (Ranieyes) Deeksha Bhandari11 April 2025 11:24 AM ISTRanieyes is the Ranibizumab Biosimilar which is an Indian Ranibizumab Biosimilar manufactured by Lupin Ltd & approved in India for various...
Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness Ruchika Sharma15 Dec 2024 1:15 PM ISTBasel: Roche has announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use...
Psoriasis Increases Risk of Retinal Vein Occlusion in Diabetic Patients, claims research Dr Riya Dave9 Sept 2024 8:45 PM ISTResearchers have found that psoriasis significantly increases the risk of retinal vein occlusion (RVO) in patients with Type 2 DM. This was based on...
Lupin completes Phase 3 trials for Lucentis biosimilar Ruchika Sharma6 Aug 2024 4:30 PM ISTMumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...
Could TGI predict risk of Retinal Vein Occlusion in at-risk individuals with a simple calculation? Dr. Shravani Dali11 July 2024 6:30 AM ISTTyG index could help as a reliable guide to identify individuals with Retinal Vein Occlusion with high risk and initiate early intervention suggests a...
Roche Vabysmo prefilled syringe bags USFDA nod for three causes of vision loss Ruchika Sharma6 July 2024 4:34 PM ISTVabysmo PFS delivers the same medicine as the currently available Vabysmo vials in an alternative, ready-to-use format.
Roche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion Ruchika Sharma29 Jun 2024 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Sun Pharma Gets CDSCO Panel Nod for Additional Indication of Ranibizumab solution for injection Dr. Divya Colin16 Jan 2024 6:00 PM ISTNew Delhi: In line with the proposal presented by the drug major Sun Pharma, the Subject Expert Committee (SEC) functional under the Central Drug...
